DELOGU, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 4.126
NA - Nord America 2.715
SA - Sud America 1.189
EU - Europa 664
AF - Africa 302
Continente sconosciuto - Info sul continente non disponibili 204
OC - Oceania 4
Totale 9.204
Nazione #
US - Stati Uniti d'America 2.568
SG - Singapore 1.481
VN - Vietnam 918
BR - Brasile 867
CN - Cina 567
HK - Hong Kong 517
BD - Bangladesh 286
IT - Italia 279
ZA - Sudafrica 220
FR - Francia 188
AR - Argentina 128
EC - Ecuador 70
IN - India 69
MX - Messico 66
ID - Indonesia 50
CO - Colombia 40
CA - Canada 39
DE - Germania 35
IQ - Iraq 34
PY - Paraguay 25
RU - Federazione Russa 25
GB - Regno Unito 23
PH - Filippine 23
VE - Venezuela 23
TR - Turchia 22
MA - Marocco 17
PK - Pakistan 17
SA - Arabia Saudita 17
ES - Italia 14
JP - Giappone 14
TH - Thailandia 14
UA - Ucraina 14
UZ - Uzbekistan 14
CL - Cile 12
MY - Malesia 12
NL - Olanda 12
EG - Egitto 10
KE - Kenya 10
PE - Perù 10
PL - Polonia 10
SC - Seychelles 10
JM - Giamaica 9
DZ - Algeria 8
KZ - Kazakistan 8
SE - Svezia 8
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
ET - Etiopia 7
NI - Nicaragua 7
IE - Irlanda 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
AL - Albania 5
BH - Bahrain 5
CH - Svizzera 5
KR - Corea 5
AO - Angola 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
FI - Finlandia 4
HN - Honduras 4
IR - Iran 4
JO - Giordania 4
MD - Moldavia 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AU - Australia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BW - Botswana 3
CR - Costa Rica 3
QA - Qatar 3
RS - Serbia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BE - Belgio 2
DM - Dominica 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
MK - Macedonia 2
RO - Romania 2
SN - Senegal 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GP - Guadalupe 1
KH - Cambogia 1
Totale 8.992
Città #
Dallas 538
San Jose 504
Hong Kong 488
Singapore 439
Council Bluffs 414
Ho Chi Minh City 332
Hanoi 199
Johannesburg 198
Lauterbourg 176
Ashburn 158
Beijing 126
Boardman 97
Los Angeles 78
São Paulo 76
Buffalo 66
New York 52
Santa Clara 51
Milan 46
Da Nang 43
Rome 37
Mexico City 35
Haiphong 31
Columbus 29
Guayaquil 24
Quito 24
Rio de Janeiro 24
Hefei 23
Phoenix 21
Munich 20
Naples 20
Brasília 19
Belo Horizonte 18
Biên Hòa 18
Hải Dương 18
Shanghai 17
Baghdad 16
Porto Alegre 16
Thái Nguyên 14
Can Tho 13
Curitiba 13
Fortaleza 13
Parma 13
Salvador 13
Tashkent 12
Thái Bình 12
Brooklyn 11
Bắc Ninh 11
Dhaka 10
Figino 10
Guangzhou 10
Joinville 10
Tianjin 10
Toronto 10
Atlanta 9
Casablanca 9
Hyderabad 9
London 9
Nairobi 9
Ninh Bình 9
Warsaw 9
Bangkok 8
Bogotá 8
Charlotte 8
Chennai 8
Frankfurt am Main 8
Jakarta 8
Jeddah 8
Kingston 8
Montreal 8
Orem 8
Quảng Ngãi 8
Seattle 8
Zhengzhou 8
Asunción 7
Cuenca 7
Córdoba 7
Guarulhos 7
Ha Long 7
Managua 7
Monte Grande 7
Montevideo 7
Santo André 7
Tokyo 7
Addis Ababa 6
Bauru 6
Brescia 6
Buenos Aires 6
Cape Town 6
Changsha 6
Chicago 6
Ciudad del Este 6
Dublin 6
Hortolândia 6
Houston 6
La Plata 6
Mumbai 6
Nuremberg 6
Philadelphia 6
Phủ Lý 6
Stockholm 6
Totale 5.015
Nome #
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 210
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 143
Comparative genomic analysis of bacteriocin genes in Lactobacillus crispatus strains 130
ADHESIVENESS OF BACILLUS-SUBTILIS STRAINS TO EPITHELIAL-CELLS CULTURED IN-VITRO 119
Current Evidence on the Relation Between Microbiota and Oral Cancer—The Role of Fusobacterium nucleatum—A Narrative Review 107
The Potential Role of the Microbiome in the Pathogenesis of Nasal Tumors: A Comprehensive Review 104
The activity of cell-free supernatant of Lactobacillus crispatus M247: a promising treatment against vaginal infections 101
Accuracy of p16 IHC in Classifying HPV-Driven OPSCC in Different Populations 89
Short-term gut microbiota’s shift after laparoscopic Roux-en-Y vs one anastomosis gastric bypass: results of a multicenter randomized control trial 86
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children 80
Carbon nanomaterials: a new way against tuberculosis 77
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 75
Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases 75
Specific immune response to M. tuberculosis and ability to in vitro control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection 71
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis Infection in Children 71
A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles 69
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 68
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung 68
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis 67
Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites 66
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children 66
Molecular typing of Mycobacterium tuberculosis strains: A fundamental tool for tuberculosis control and elimination 66
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 66
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division 65
Alternative therapies against Mycobacterium abscessus infections 64
Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy 64
Secrets and lies of host-microbial interactions: MHC restriction and trans-regulation of T cell trafficking conceal the role of microbial agents on the edge between health and multifactorial/complex diseases 62
Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease 62
Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease. 62
The PPE domain of PPE17 is responsible for its surface localization and can be used to express heterologous proteins on the mycobacterial surface. 61
The spectrum of tuberculosis infection: new perspectives in the era of biologics 60
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 60
Lifestyles and ageing: targeting key mechanisms to shift the balance from unhealthy to healthy ageing 60
HINTT working group within the GABRIEL network. (2020) Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study 60
Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature 58
Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis 57
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 57
C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay 56
HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice 56
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 55
Immunomodulation by gut microbiota: role of Toll-like receptor expressed by T cells 54
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 54
Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children 53
Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 of Mycobacterium tuberculosis 53
Development of antitubercular compunds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies 53
Unraveling the Gut Microbiome–Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology 53
The biology of mycobacterium tuberculosis infection 52
Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli 51
M tuberculosis in the adjuvant modulates time of appearance of CNS-specific effector T cells in the spleen through a polymorphic site of TLR2. 51
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study 51
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2 51
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants 51
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 51
Specific T Cells Restore the Autophagic Flux Inhibited by Mycobacterium tuberculosis in Human Primary Macrophages 50
Mycobacterium tuberculosis virulence: insights and impact on vaccine development 50
Prospective Evaluation of Epidemiological, Clinical, and Microbiological Features of Pandemic Influenza A (H1N1) Virus Infection in Italy 50
Bacillus cereus keratitis associated with contact lens wear 50
Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector 50
Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study 50
Children and COVID-19: Microbiological and immunological insights 49
Tuberculosis patients are characterized by a low-IFN-gamma/high-TNF-alpha response to methylated HBHA produced in M. smegmatis 49
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis 49
Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences 48
PPE_MPTR genes are differentially expressed by Mycobacterium tuberculosis in vivo 48
In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion 48
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 47
A Twenty-year Retrospective Study of Pediatric Tuberculosis in Two Tertiary Hospitals in Rome 46
Low Prevalence of HPV Related Oropharyngeal Carcinogenesis in Northern Sardinia 46
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy 46
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 46
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 46
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection 46
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 45
Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis 45
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. 45
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 45
Understanding cutaneous tuberculosis: two clinical cases 45
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection 45
First description of agonist and antagonist IP-10 in urine of patients with active TB 45
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 44
HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice 44
Suspected transmission of tuberculosis in a maternity ward from a smear-positive nurse: preliminary results of clinical evaluations and testing of neonates potentially exposed, Rome, Italy, 1 January to 28 July 2011 44
Monocyte‐to‐lymphocyte, neutrophil‐to‐lymphocyte and neutrophil‐to‐monocyte plus lymphocyte ratios in children with active tuberculosis: A multicentre study 44
Mycobacterium smegmatis Expressing a Chimeric Protein MPT64-Proteolipid Protein (PLP) 139-151 Reorganizes the PLP-Specific T Cell Repertoire Favoring a CD8-Mediated Response and Induces a Relapsing Experimental Autoimmune Encephalomyelitis 44
Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children 44
QuantiFERON TB Gold: a new method for latent tuberculosis infection 43
Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice 43
Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children. On Behalf Of The Gemelli-Pediatric Covid-Team 43
Isolation and identification of Mycobacterium neoaurum from a patient with urinary infection 43
Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome 42
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 42
DNA Vaccination against Tuberculosis: Expression of an Ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity 42
PE_PGRS proteins of Mycobacterium tuberculosis: A specialized molecular task force at the forefront of host-pathogen interaction 42
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay 42
Structural Basis of PE_PGRS Polymorphism, a Tool for Functional Modulation 42
Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites 42
Laser-Mediated antibacterial effects of Few- and Multi-Layer Ti3C2Tx MXenes 42
PGRS domain structures: Doomed to sail the mycomembrane 42
Heparin binding haemagglutinin as potential diagnostic marker of Mycobacterium bovis 42
Critical Research Concepts in TB Vaccine Development. 41
Totale 5.897
Categoria #
all - tutte 29.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 1 0 0 0 0 1 2
2022/20234 1 0 0 0 0 0 0 0 3 0 0 0
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025822 0 1 1 0 0 1 2 1 2 1 237 576
2025/20267.451 209 965 1.398 886 777 252 693 261 920 433 386 271
2026/2027919 408 511 0 0 0 0 0 0 0 0 0 0
Totale 9.204